Related Experiment Video
Updated: Jan 15, 2026
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Re-evaluated Treatment Outcomes of Bacteriologically Positive Patients with Tuberculosis Registered at an Urban
Samuel Daka1, Masaki Ota2, Graham Kapalu Samungole3
1Technical Department, Japan Anti-tuberculosis Association Zambia, Lusaka, Zambia.
Background:
The objective is to re-evaluate treatment outcomes of all bacteriologically positive patients with tuberculosis (TB) registered at Facility X in 2023.
Methods:
A retrospective cohort study was conducted on treatment outcomes of patients with TB using TB treatment and laboratory TB registers and treatment cards. Patients with incorrect treatment outcomes and those who were not evaluated by the facility had correct treatment outcomes assigned. In addition, treatment outcomes for patients who were transferred out were retrieved.
Results:
A total of 350 patients with bacteriologically positive TB were registered at facility X in 2023. The number of male patients was 274 (78%), the age of the patients ranged from 2.9 to 80 years, and 262 (74.9%) were new patients. The health facility managed to evaluate 340 (97%) patients, of whom 334 (95.4%) were correctly evaluated, while 16 (4.6%) were either incorrectly evaluated or not evaluated at all. As a result of this re-evaluation, the proportion of the evaluated patients increased from 97% (340 of 350 patients) to 99.4% (348 of 350 patients). The cure rate rose from 90.6% to 92.2% and the treatment success rate increased from 90.9% to 92.9%.
Conclusion:
This study has demonstrated that it is possible to evaluate almost all patients with TB at the end of their treatment. Inaccuracies in reporting TB data can negatively affect the implementation of TB programs. Health facilities should strive to correctly evaluate all patients with TB.
More Related Videos
Related Concept Videos
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: